Targeted Therapy in BRAF p.K601E-Driven NSCLC: Case Report and Literature Review

被引：11

作者：

Saalfeld, Felix C. ^{[1
,2
]}

Wenzel, Carina ^{[2
,3
]}

Aust, Daniela E. ^{[2
,3
]}

Wermke, Martin ^{[1
,2
]}

机构：

[1] Tech Univ, Univ Hosp, Clin Internal Med 1, Dresden, Germany

[2] Natl Network Genom Med Lung Canc, Cologne, Germany

[3] Tech Univ, Univ Hosp, Dept Pathol, Dresden, Germany

来源：

JCO PRECISION ONCOLOGY | 2020年 / 4卷

关键词：

D O I：

10.1200/PO.20.00187

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1163 / 1166

页数：4

共 24 条

[1] Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma [J].

Bowyer, Samantha E. ;

Rao, Aparna D. ;

Lyle, Megan ;

Sandhu, Shahneen ;

Long, Georgina V. ;

McArthur, Grant A. ;

Raleigh, Jeanette M. ;

Hicks, Rodney J. ;

Millward, Michael .

MELANOMA RESEARCH, 2014, 24 (05) :504-508

[2] Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas [J].

Campbell, Joshua D. ;

Alexandrov, Anton ;

Kim, Jaegil ;

Wala, Jeremiah ;

Berger, Alice H. ;

Pedamallu, Chandra Sekhar ;

Shukla, Sachet A. ;

Guo, Guangwu ;

Brooks, Angela N. ;

Murray, Bradley A. ;

Imielinski, Marcin ;

Hu, Xin ;

Ling, Shiyun ;

Akbani, Rehan ;

Rosenberg, Mara ;

Cibulskis, Carrie ;

Ramachandran, Aruna ;

Collisson, Eric A. ;

Kwiatkowski, David J. ;

Lawrence, Michael S. ;

Weinstein, John N. ;

Verhaak, Roel G. W. ;

Wu, Catherine J. ;

Hammerman, Peter S. ;

Cherniack, Andrew D. ;

Getz, Gad ;

Artyomov, Maxim N. ;

Schreiber, Robert ;

Govindan, Ramaswamy ;

Meyerson, Matthew .

NATURE GENETICS, 2016, 48 (06) :607-+

[3] Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non-Small Cell Lung Cancer [J].

Cardarella, Stephanie ;

Ogino, Atsuko ;

Nishino, Mizuki ;

Butaney, Mohit ;

Shen, Jeanne ;

Lydon, Christine ;

Yeap, Beow Y. ;

Sholl, Lynette M. ;

Johnson, Bruce E. ;

Jaenne, Pasi A. .

CLINICAL CANCER RESEARCH, 2013, 19 (16) :4532-4540

[4] BRAFL597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors [J].

Dahlman, Kimberly Brown ;

Xia, Junfeng ;

Hutchinson, Katherine ;

Ng, Charles ;

Hucks, Donald ;

Jia, Peilin ;

Atefi, Mohammad ;

Su, Zengliu ;

Branch, Suzanne ;

Lyle, Pamela L. ;

Hicks, Donna J. ;

Bozon, Viviana ;

Glaspy, John A. ;

Rosen, Neal ;

Solit, David B. ;

Netterville, James L. ;

Vnencak-Jones, Cindy L. ;

Sosman, Jeffrey A. ;

Ribas, Antoni ;

Zhao, Zhongming ;

Pao, William .

CANCER DISCOVERY, 2012, 2 (09) :791-797

[5] Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations [J].

Dankner, Matthew ;

Rose, April A. N. ;

Rajkumar, Shivshankari ;

Siegel, Peter M. ;

Watson, Ian R. .

ONCOGENE, 2018, 37 (24) :3183-3199

[6] Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort [J].

Gautschi, Oliver ;

Milia, Julie ;

Cabarrou, Bastien ;

Bluthgen, Marie-Virginia ;

Besse, Benjamin ;

Smit, Egbert F. ;

Wolf, Juergen ;

Peters, Solange ;

Frueh, Martin ;

Koeberle, Dieter ;

Oulkhouir, Youssouf ;

Schuler, Martin ;

Curioni-Fontecedro, Alessandra ;

Huret, Benjamin ;

Kerjouan, Mallorie ;

Michels, Sebastian ;

Pall, Georg ;

Rothschild, Sacha ;

Schmid-Bindert, Gerald ;

Scheffler, Matthias ;

Veillon, Remi ;

Wannesson, Luciano ;

Diebold, Joachim ;

Zalcman, Gerard ;

Filleron, Thomas ;

Mazieres, Julien .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (10) :1451-1457

[7] Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing [J].

Imielinski, Marcin ;

Berger, Alice H. ;

Hammerman, Peter S. ;

Hernandez, Bryan ;

Pugh, Trevor J. ;

Hodis, Eran ;

Cho, Jeonghee ;

Suh, James ;

Capelletti, Marzia ;

Sivachenko, Andrey ;

Sougnez, Carrie ;

Auclair, Daniel ;

Lawrence, Michael S. ;

Stojanov, Petar ;

Cibulskis, Kristian ;

Choi, Kyusam ;

de Waal, Luc ;

Sharifnia, Tanaz ;

Brooks, Angela ;

Greulich, Heidi ;

Banerji, Shantanu ;

Zander, Thomas ;

Seidel, Danila ;

Leenders, Frauke ;

Ansen, Sascha ;

Ludwig, Corinna ;

Engel-Riedel, Walburga ;

Stoelben, Erich ;

Wolf, Juergen ;

Goparju, Chandra ;

Thompson, Kristin ;

Winckler, Wendy ;

Kwiatkowski, David ;

Johnson, Bruce E. ;

Jaenne, Pasi A. ;

Miller, Vincent A. ;

Pao, William ;

Travis, William D. ;

Pass, Harvey I. ;

Gabriel, Stacey B. ;

Lander, Eric S. ;

Thomas, Roman K. ;

Garraway, Levi A. ;

Getz, Gad ;

Meyerson, Matthew .

CELL, 2012, 150 (06) :1107-1120

[8] Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients [J].

Kim, Dae Won ;

Haydu, Lauren E. ;

Joon, Aron Y. ;

Bassett, Roland L. ;

Siroy, Alan E. ;

Tetzlaff, Michael T. ;

Routbort, Mark J. ;

Amaria, Rodabe N. ;

Wargo, Jennifer A. ;

McQuade, Jennifer L. ;

Kemnade, Jan ;

Hwu, Patrick ;

Woodman, Scott E. ;

Roszik, Jason ;

Kim, Kevin B. ;

Gershenwald, Jeffrey E. ;

Lazar, Alexander J. ;

Davies, Michael A. .

CANCER, 2017, 123 (08) :1372-1381

[9] Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor [J].

Kim, Kevin B. ;

Kefford, Richard ;

Pavlick, Anna C. ;

Infante, Jeffrey R. ;

Ribas, Antoni ;

Sosman, Jeffrey A. ;

Fecher, Leslie A. ;

Millward, Michael ;

McArthur, Grant A. ;

Hwu, Patrick ;

Gonzalez, Rene ;

Ott, Patrick A. ;

Long, Georgina V. ;

Gardner, Olivia S. ;

Ouellet, Daniele ;

Xu, Yanmei ;

DeMarini, Douglas J. ;

Le, Ngocdiep T. ;

Patel, Kiran ;

Lewis, Karl D. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) :482-489

[10] Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations [J].

Kinno, T. ;

Tsuta, K. ;

Shiraishi, K. ;

Mizukami, T. ;

Suzuki, M. ;

Yoshida, A. ;

Suzuki, K. ;

Asamura, H. ;

Furuta, K. ;

Kohno, T. ;

Kushima, R. .

ANNALS OF ONCOLOGY, 2014, 25 (01) :138-142

← 1 2 3 →